← Leaderboards
Patrick S. Kamath
Mayo Clinic Coll Of Medicine, Rochester
$941,618
Attributed
$1,883,236
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $380.2K · FY2018–22$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,883,236 · 2
By mechanism
U01$1,883,236 · 1
M01$0 · 1
Top collaborators
- Vijay H Shah6 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Vijay H Shah$27,167,769
- W. Ray Kim$11,120,452
- Steven J Jacobsen$6,827,708
- Vicente E Torres$21,998,835
- E R Dickson$1,710,269
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchEligibility DeterminationCollectionEffective TherapyActive MethodAlcoholic HepatitisBaseAdrenal Cortex HormonesCatalystEducational WorkshopEconomic BurdenAnakinraClinical TrialsClinical Trials DesignEfficacy TrialConduct Clinical TrialsAlcoholic Liver DiseasesDatabasesData Coordinating CenterData SetAlcoholsDrug TestingEvidence BaseFda Approved
Grant awards (9)
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 5/9$369,000
U01 · FY2022 · AA
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 5/9$380,152
U01 · FY2021 · AA
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 5/9$380,152
U01 · FY2020 · AA
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 5/9$380,152
U01 · FY2019 · AA
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 5/9$369,000
U01 · FY2018 · AA
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 5/9$4,780
U01 · FY2018 · AA
SANDOSTATIN LAR IN PATIENTS WITH CIRRHOSIS$0
M01 · FY2002 · RR
SANDOSTATIN LAR IN PATIENTS WITH CIRRHOSIS$0
M01 · FY2001 · RR
SANDOSTATIN LAR IN PATIENTS WITH CIRRHOSIS$0
M01 · FY2000 · RR